A Study of Uveitis in Children <18 Years of Age

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07518134

Acronym

UV1

Enrollment

300

Registered

2026-04-08

Start date

2026-04-14

Completion date

2028-04-01

Last updated

2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uveitis

Keywords

pediatric, uveitis

Brief summary

The goal of this observational study is to collect data regarding clinical features and current/past treatments in children under 18 with uveitis. The main questions it aims to answer are: * What are the frequency of uveitis subtypes in children? * What are clinical and demographic characteristics overall and within each type of uveitis? Participants will complete one enrollment visit with their doctor. Participants with uveitis onset \<6 months from enrollment date will also partake in a 12 month chart review.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

No minimum to 17 Years

Healthy volunteers

Inclusion criteria

* Age: * Incident cases (onset ≤ 6 months) \<17 years * Established cases (onset \> 6 months) \<18 years * Diagnosis of any type of uveitis (infectious or noninfectious) in any location except traumatic and post-operative uveitis. * Active or inactive uveitis with any treatment status (current / prior / none \[but under surveillance\]).

Exclusion criteria

* Bilateral uveitis with differing etiologies * Traumatic uveitis * Post-operative uveitis * Immediate family member (spouse, biological or legal guardian, child, sibling, parent) who is an investigative site personnel directly affiliated with this study or who is an employee of JAEB Center for Health Research. * Ocular disease related to Retinoblastoma, Coat's disease, retinitis pigmentosa, inherited retinal degeneration, Juvenile xanthogranuloma (JXG), or leukemia/malignancy within the eye.

Design outcomes

Primary

Measure	Time frame
Frequency of uveitis subtypes in children <18 years of age	Enrollment

Countries

United States

Contacts

CONTACTJulianne Zawadzki, MSPH

jrobinson@jaeb.org813-975-8690

CONTACTRaymond Kraker, MSPH

rkraker@jaeb.org8139758690

STUDY_CHAIRKara C LaMattina, MD

Department of Ophthalmology, Boston University School of Medicine

STUDY_CHAIRVirginia Miraldi Utz, MD

Children's Hospital Medical Center, Cincinnati

Outcome results